🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07266051
Starting soon Observational

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

NCT07266051 · tracked via the Priya Life Science China tracker
Sponsor
Xiamen Hospital of Traditional Chinese Medicine
Phase
Observational
Started
2025-12
Last updated
2025-12-18

Condition(s) studied

NMOSD

Investigational drug(s) / intervention(s)

Sex hormone assaySex hormone assay

Sex hormone assay: This study will explore and validate the characteristics of sex hormone levels in MNMOSD

Sex hormone assay: This study will explore the comparison of sex hormone levels between a healthy control group and MNMOSD

Study summary

This study aims to characterize sex hormone alterations and their potential clinical significance in NMOSD patients from Southern China through comprehensive hormonal profiling.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria Inclusion Criteria for the NMOSD Patient Group * Aged 18 years or older, regardless of sex * Fulfilled the diagnostic criteria for Neuromyelitis Optica Spectrum Disorders as defined by the 2021 Chinese guidelines for the diagnosis and management of NMOSD * Seropositive for AQP4-IgG * Provided informed consent by the participant or their legal guardian Inclusion Criteria for the Healthy Control Group * Aged 18 years or older, regardless of sex * Gender- and age-matched healthy individuals * Provided informed consent by the participant or their legal guardian Exclusion Criteria * Diagnosis of other serious systemic diseases (e.g., malignancy) * Presence of severe psychiatric disorders that would preclude compliance with study procedures and/or follow-up assessments * History of infectious pathologies of the central nervous system * Those with severe liver and kidney function impairment or dysfunction of other vital organs * Patients with other conditions that do not allow participation in clinical research * Patients allergic to gadolinium-DPTA * Patients with other conditions that do not allow participation in clinical research

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
The First Affiliated Hospital of Xiamen university Xiamen Fujian
The Second Affiliated Hospital of Xiamen Medical College Xiamen Fujian
Xiamen Hospital of Traditional Chinese Medicine Xiamen Fujian
Zhongshan Hospital (Xiamen), Fudan University Xiamen Fujian
Zhongshan Hospital Xiamen University Xiamen Fujian

More Xiamen Hospital of Traditional Chinese Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07266051 on ClinicalTrials.gov ↗ ← All trials in China